EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 32 / No 8-9 (Août–Septembre 2016) Med Sci (Paris), 32 8-9 (2016) 674-677 References
Free Access
Issue
Med Sci (Paris)
Volume 32, Number 8-9, Août–Septembre 2016
Page(s) 674 - 677
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20163208005
Published online 12 September 2016
  1. Marques Sousa C, Humbert S. Huntingtin: here, there, everywhere! J Huntingtons Dis 2013 ; 2 : 395–403. [PubMed] [Google Scholar]
  2. Elias S, McGuire JR, Yu H, et al. Huntingtin is required for epithelial polarity through RAB11A-mediated apical trafficking of PAR3-aPKC. PLoS Biol 2015 ; 13 : e1002142. [CrossRef] [PubMed] [Google Scholar]
  3. Elias S, Thion MS, Yu H, et al. Huntingtin regulates mammary stem cell division and differentiation. Stem Cell Rep 2014 ; 2 : 491–506. [CrossRef] [Google Scholar]
  4. Moreira Sousa C, McGuire JR, Thion MS, et al. The Huntington disease protein accelerates breast tumour development and metastasis through ErbB2/HER2 signalling. EMBO Mol Med 2013 ; 5 : 309–325. [CrossRef] [PubMed] [Google Scholar]
  5. Thion MS, McGuire JR, Sousa CM, et al. Unraveling the role of huntingtin in breast cancer metastasis. J Natl Cancer Inst 2015 ; 107 : djv208. [PubMed] [Google Scholar]
  6. Sorensen SA, Fenger K, Olsen JH. Significantly lower incidence of cancer among patients with Huntington disease: An apoptotic effect of an expanded polyglutamine tract? Cancer 1999 ; 86 : 1342–1346. [PubMed] [Google Scholar]
  7. Ji J, Sundquist K, Sundquist J. Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden. Lancet Oncol 2012 ; 13 : 642–648. [CrossRef] [PubMed] [Google Scholar]
  8. Charafe-Jauffret E, Chaffanet M, Bertucci F, et al. Les cancers du sein : vers un modèle cellulaire et moléculaire intégré. Med Sci (Paris) 2007 ; 23 : 626–632. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  9. Tokes AM, Szasz AM, Juhasz E, et al. Expression of tight junction molecules in breast carcinomas analysed by array PCR and immunohistochemistry. Pathol Oncol Res 2012 ; 18 : 593–606. [CrossRef] [PubMed] [Google Scholar]
  10. Hoover KB, Liao SY, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998 ; 153 : 1767–1773. [CrossRef] [PubMed] [Google Scholar]
  11. Martin TA, Watkins G, Mansel RE, et al. Loss of tight junction plaque molecules in breast cancer tissues is associated with a poor prognosis in patients with breast cancer. Eur J Cancer 2004 ; 40 : 2717–2725. [CrossRef] [PubMed] [Google Scholar]
  12. Lo Sardo V, Zuccato C, Gaudenzi G, et al. An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin. Nat Neurosci 2012 ; 15 : 713–721. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.